Therapy Areas: Respiratory
8 July 2020 - - US-based Ridgeback Biotherapeutics has started enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801, the company said.

The new trial will be conducted u...
7 July 2020 - - The first patient has been enrolled in its Phase 2 study to assess the safety and efficacy of CSL312 (garadacimab, Factor XIIa antagonist monoclonal antibody) to treat patien...
7 July 2020 - - US-based clinical stage biotechnology and pharmaceutical company Reven Holdings, Inc is highlighting the publication two peer-reviewed expert articles authored by its chief medical off...
7 July 2020 - Biotechnology company Anixa Biosciences Inc (NASDAQ:ANIX) and partner OntoChem announced Monday the completion of the initial in silico screening process and have identified an additiona...
7 July 2020 - Laboratory company Cellenkos Inc announced on Monday that Johns Hopkins University Hospital has announced encouraging data from the treatment of COVID-19 induced acute respiratory distre...
6 July 2020 - - The first patient has been enrolled in biotherapeutics company CSL Behring's Phase 2 study to assess the safety and efficacy of CSL312 (garadacimab, Factor XIIa antagoni...